1. Home
  2. BTMD vs HOWL Comparison

BTMD vs HOWL Comparison

Compare BTMD & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.10

Market Cap

39.0M

Sector

Health Care

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

SELL

Current Price

$0.92

Market Cap

46.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BTMD
HOWL
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
46.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BTMD
HOWL
Price
$1.10
$0.92
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $2.61
N/A
AVG Volume (30 Days)
123.7K
★ 623.8K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 722.22
18.40
EPS
★ N/A
N/A
Revenue
★ $192,219,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.45
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.10
$0.27
52 Week High
$3.26
$1.94

Technical Indicators

Market Signals
Indicator
BTMD
HOWL
Relative Strength Index (RSI) 27.63 54.32
Support Level N/A $0.92
Resistance Level $1.68 $0.99
Average True Range (ATR) 0.07 0.04
MACD -0.00 -0.02
Stochastic Oscillator 1.52 30.77

Price Performance

Historical Comparison
BTMD
HOWL

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: